Sarah H. Lisanby, MD
Lawrence C. Katz Professor and Department Chair
Psychiatry and Behavioral Sciences
Duke University School of Medicine
Primary Care Physicians
$0 for UF Participants
$35.00 non-UF Participants
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.
Requirements for Successful Completion
- This CME activity consists of an educational component (audio lecture in an electronic format, which is followed by an online post-test).
- Certificates are awarded upon successful completion (80% proficiency) of the post-test.
- In order to receive credit, participants must view the presentation in its entirety.
- The University of Florida College of Medicine will report CME credit to CE Broker when applicable.
As a result of participation in this activity, participants should be able to:
1. Define and describe the new forms of neuromodulation available in psychiatry today.
2. Identify the proper indications and position in treatment algorithms for new forms of brain stimulation.
3. Recognize the risks of neurostimulation techniques, notably the potential impact on cognition.
Dr. Lisanby has disclosed that in the past 12 months, she has received grant/research support from NeoSync, Brainsway, St. Jude Medical, NIH, and Stanley Foundation. No one else in a position to control content has any financial relationships to disclose
Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: November 9, 2015
Expiration Date: November 8, 2019